AORTIC VALVE NEOCUSPIDISATION VERSUS AORTIC VALVE REPLACEMENT WITH AORTIC VALVE PROSTHESIS- A NON INFERIORITY TRIA
Not Applicable
- Conditions
- Health Condition 1: I359- Nonrheumatic aortic valve disorder, unspecifiedHealth Condition 2: I069- Rheumatic aortic valve disease, unspecified
- Registration Number
- CTRI/2023/06/053754
- Lead Sponsor
- Dr Reena Jagadeesha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients who will undergo AV Neo cuspidisation for aortic valve disease and AV Replacement either by mechanical/ bioprosthetic valve
Exclusion Criteria
1)Patients undergoing concominant procedure like cabg/other valve surgery along with aortic valve surgery.
2) Patients who do not give consent for participation in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean & peak gradient across AV prosthesis & AV Neo group using Transthoracic 2d echocardiography.Timepoint: 1month & 6months
- Secondary Outcome Measures
Name Time Method incidence of complications like recurrence of AR/ AS, infective endocarditis, suture dehiscence, paravalvular leak or stuck valve /root abscess in both groups during follow up periodTimepoint: 1month & 6months;Post operative complications & duration of ICU stayTimepoint: 1month & 6months;The NYHA grade of symptomsTimepoint: 1month & 6months